Literature DB >> 12922108

A synthetic peptide containing the consensus sequence of the G-H loop region of foot-and-mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge.

Luis L Rodriguez1, Jose Barrera, Ed Kramer, Juan Lubroth, Fred Brown, William T Golde.   

Abstract

A pilot study was carried out in cattle to determine the immunogenicity of a synthetic consensus peptide comprising the G-H loop region of foot-and-mouth disease virus (FMDV) type-O VP1 and a non-VP1 T-helper (Th) epitope. Cattle vaccinated intramuscularly either once (n = 5) or twice (n = 4) with 50 microg of the peptide preparation at a 21-day interval developed antibodies to the peptide as determined by ELISA with the exception of one steer that received a single dose. However, neutralizing antibody titers against FMDV type-O were modest and all animals presented with clinical FMD signs upon challenge 21 days after the last vaccination. In contrast, four of the five animals inoculated with an inactivated FMD type-O commercially prepared vaccine developed neutralizing antibodies and were fully protected against clinical disease following virus challenge 21 days post-vaccination (dpv). Nucleotide sequence comparison of the VP1 region between the challenge virus and RT-PCR products recovered from a lesion of the peptide-vaccinated animal with the highest neutralizing antibody titer 5 days post-challenge (dpc) showed no evidence for selection of a neutralization-resistant mutant. We conclude that although the synthetic peptide induced an antibody response in cattle, it failed to confer protection against FMDV challenge.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12922108     DOI: 10.1016/s0264-410x(03)00364-5

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

1.  Immune potential of a novel multiple-epitope vaccine to FMDV type Asia 1 in guinea pigs and sheep.

Authors:  Jun-jun Shao; Jing-feng Wang; Hui-yun Chang; Ji-xing Liu
Journal:  Virol Sin       Date:  2011-06-12       Impact factor: 4.327

2.  Promising multiple-epitope recombinant vaccine against foot-and-mouth disease virus type O in swine.

Authors:  Jun-Jun Shao; Chung Kai Wong; Tong Lin; Shuk Kwan Lee; Guo-Zheng Cong; Fion Wai Yee Sin; Jun-Zheng Du; Shan-Dian Gao; Xiang-Tao Liu; Xue-Peng Cai; Yong Xie; Hui-Yun Chang; Ji-Xing Liu
Journal:  Clin Vaccine Immunol       Date:  2010-11-17

3.  Monoclonal and polyclonal antibodies specific for foot and mouth disease virus type A and type O VP1.

Authors:  Jin Gu Cho; Yeong Joon Jo; Jong-Hyuk Sung; Jang-Kwan Hong; Ji-Hyeon Hwang; Jong-Hyeon Park; Kwang-Nyeong Lee; Sang Gyu Park
Journal:  Hybridoma (Larchmt)       Date:  2012-10

4.  An M2e-based synthetic peptide vaccine for influenza A virus confers heterosubtypic protection from lethal virus challenge.

Authors:  Ji-Hong Ma; Fu-Ru Yang; Hai Yu; Yan-Jun Zhou; Guo-Xin Li; Meng Huang; Feng Wen; Guangzhi Tong
Journal:  Virol J       Date:  2013-07-09       Impact factor: 4.099

5.  Identification of H-2d restricted T cell epitope of foot-and-mouth disease virus structural protein VP1.

Authors:  Xin-Sheng Liu; Yong-Lu Wang; Yong-Guang Zhang; Yu-Zhen Fang; Li Pan; Jian-Liang Lu; Peng Zhou; Zhong-Wang Zhang; Shou-Tian Jiang
Journal:  Virol J       Date:  2011-09-07       Impact factor: 4.099

6.  Bacterial Toxin Fusion Proteins Elicit Mucosal Immunity against a Foot-and-Mouth Disease Virus Antigen When Administered Intranasally to Guinea Pigs.

Authors:  Sreerupa Challa; Steven M Szczepanek; Debra Rood; Roger W Barrette; Lawrence K Silbart
Journal:  Adv Virol       Date:  2011-09-22

7.  Dendrimeric peptides can confer protection against foot-and-mouth disease virus in cattle.

Authors:  Ivana Soria; Valeria Quattrocchi; Cecilia Langellotti; Mariela Gammella; Sebastian Digiacomo; Beatriz Garcia de la Torre; David Andreu; Maria Montoya; Francisco Sobrino; Esther Blanco; Patricia Zamorano
Journal:  PLoS One       Date:  2017-09-26       Impact factor: 3.240

8.  Immunogenicity evaluation of MS2 phage-mediated chimeric nanoparticle displaying an immunodominant B cell epitope of foot-and-mouth disease virus.

Authors:  Guoqiang Wang; Yunchao Liu; Hua Feng; Yumei Chen; Suzhen Yang; Qiang Wei; Juan Wang; Dongmin Liu; Gaiping Zhang
Journal:  PeerJ       Date:  2018-05-23       Impact factor: 2.984

9.  Immune Response and Partial Protection against Heterologous Foot-and-Mouth Disease Virus Induced by Dendrimer Peptides in Cattle.

Authors:  I Soria; V Quattrocchi; C Langellotti; M Pérez-Filgueira; J Pega; V Gnazzo; S Romera; J Schammas; D Bucafusco; S Di Giacomo; Beatriz G de la Torre; D Andreu; F Sobrino; E Blanco; P Zamorano
Journal:  J Immunol Res       Date:  2018-04-18       Impact factor: 4.818

Review 10.  Laboratory animal models to study foot-and-mouth disease: a review with emphasis on natural and vaccine-induced immunity.

Authors:  Mohammed Habiela; Julian Seago; Eva Perez-Martin; Ryan Waters; Miriam Windsor; Francisco J Salguero; James Wood; Bryan Charleston; Nicholas Juleff
Journal:  J Gen Virol       Date:  2014-07-07       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.